✦ LIBER ✦

Neuroprotection for Parkinson's disease: a call for clinically riven experimental design

✍ Scribed by Erwan Bezard

Book ID: 114407420
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 77 KB
Volume: 2
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(03)00432-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective clinical strategies for

Neuroprotective clinical strategies for Parkinson's disease

✍ Dr. Ira Shoulson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 2 views

Neuroinflammation in Parkinson's disease

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

✍ Etienne C Hirsch; Stéphane Hunot 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 644 KB

Neuroprotective agents for clinical tria

Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment

✍ Ravina, B.M.; Fagan, S.C.; Hart, R.G.; Hovinga, C.A.; Murphy, D.D.; Dawson, T.M. 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 338 KB

Clinical neuroprotection in Parkinson's

Clinical neuroprotection in Parkinson's disease — Still waiting for the breakthrough

✍ Matthias Löhle; Heinz Reichmann 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Targets for neuroprotection in Parkinson

Targets for neuroprotection in Parkinson's disease

✍ Talene A. Yacoubian; David G. Standaert 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 353 KB

A responsive outcome for Parkinson's dis

A responsive outcome for Parkinson's disease neuroprotection futility studies

✍ Jordan J. Elm; Christopher G. Goetz; Bernard Ravina; Kathleen Shannon; George Fr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views